Orthofix Medical CAO sells $1,196 in stock

Published 04/04/2025, 21:26
Orthofix Medical CAO sells $1,196 in stock

Gillespie Geoffrey C, Chief Accounting Officer at Orthofix Medical (TASE:BLWV) Inc. (NASDAQ:OFIX), a medical device company with annual revenues of $799 million and a market capitalization of $572 million, recently sold 76 shares of the company’s common stock. According to InvestingPro data, the company maintains strong liquidity with a current ratio of 2.57. The shares were sold at a price of $15.74 each, amounting to a total transaction value of $1,196. This sale was conducted to satisfy tax withholding obligations related to the settlement of restricted stock units, as mandated by the company’s Compensation and Talent Development Committee. Following this transaction, Gillespie retains ownership of 42,445 shares. InvestingPro analysis indicates the stock is currently undervalued, with additional insights available in the comprehensive Pro Research Report, which offers detailed analysis of this and 1,400+ other US stocks.

In other recent news, Orthofix International reported fourth-quarter earnings with revenue reaching $215.7 million, surpassing the consensus estimate of $212.4 million. The company’s EBITDA also exceeded expectations, coming in at $23.9 million. Despite these positive results, Orthofix’s revenue guidance for 2025 fell short of analyst projections, estimating between $818 million and $826 million compared to a projected $847 million. This adjustment reflects the discontinuation of certain product lines, which previously contributed significantly to revenue. Additionally, Orthofix received FDA 510(k) clearance and a European CE Mark for its TrueLok Elevate Transverse Bone Transport System, marking a significant development in its product offerings.

The company also announced the appointment of Vickie Capps to its Board of Directors, bringing her extensive finance expertise to the team. Analyst firms have weighed in on Orthofix’s performance, with Citizens JMP maintaining a Market Perform rating and BTIG holding a Neutral rating. Meanwhile, Canaccord Genuity initiated coverage with a Buy rating, citing the company’s strategic initiatives and product portfolio. These developments indicate Orthofix’s ongoing focus on innovation and strategic growth within the medical technology sector.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.